Clinical outcome of bioresorbable scaffold for the treatment of coronary artery disease

Session comprising selected EuroPCR 2014 abstract submissions

Presentations available when logged in:

  • ABSORB everolimus-eluting bioresorbable scaffold in coronary interventions: 6-month results of a single centre "real world" registry
  • Bioresorbable scaffold is associated with a low rate of coronary events in an all-comer population in the Middle East
  • Single centre experience with the first 500 everolimus-eluting bioresorbable scaffold implantations in all comers: procedural and in-hospital outcomes
  • ABSORB FIRST: an interim report on baseline characteristics, acute performance from the first 500+ patients from a prospective, multicentre, global...
  • Impact of post-dilatation on one-year clinical outcomes of a large cohort of patients treated with the Absorb bioresorbable scaffold
  • Long-term clinical data of the BIOSOLVE-I study with the paclitaxel-eluting absorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis
  • Multi-centre evaluation of the novolimus-eluting, fully bioresorbable coronary scaffold: 1-year clinical and imaging endpoints